​

Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?

OverviewForecastFinancialsChart

Cognition Therapeutics Ownership Summary

Cognition Therapeutics is owned by 21.44% institutional investors, 2.25% insiders, and 76.31% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 8.25% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.30% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCognition Therapeutics21.44%2.25%76.31%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp6.00M8.25%$4.56M
Vanguard group3.32M4.26%$4.48M
Davenport2.89M3.98%$2.20M
Tang capital management1.20M1.88%$1.62M
Renaissance1.12M1.54%$848.47K
Chescapmanager997.03K1.37%$757.24K
Blackrock funding, inc. /de968.36K1.33%$735.47K
Geode capital management920.21K1.26%$699.23K
Hilton capital management548.95K0.75%$416.93K
Vanguard fiduciary trust463.68K0.64%$352.40K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp6.00M8.63%$4.56M
Cm management400.00K0.25%$303.80K
Dauntless investment group431.00K0.22%$327.35K
Chescapmanager997.03K0.07%$757.24K
Tang capital management1.20M0.06%$1.62M
American financial group205.00K0.06%$155.70K
Hilton capital management548.95K0.03%$416.93K
Davenport2.89M0.01%$2.20M
Fca corp /tx52.54K0.01%$39.90K
Voss capital200.00K0.01%$151.90K

Top Buyers

HolderShares% AssetsChange
Tang capital management1.20M0.06%1.20M
Vanguard group3.32M0.00%635.91K
Vanguard fiduciary trust463.68K0.00%463.68K
Cm management400.00K0.25%200.00K
Xtx topco195.80K0.00%158.58K

Top Sellers

HolderShares% AssetsChange
Acadian asset management---701.94K
Awm investment company---650.00K
Timelo investment management---361.40K
Aigh capital management---300.77K
Jane street group370.14K--244.12K

New Positions

HolderShares% AssetsChangeValue
Tang capital management1.20M0.06%1.20M$1.62M
Vanguard fiduciary trust463.68K0.00%463.68K$352.40K
Hrt financial lp153.00K0.00%153.00K$116.00K
Catalyst funds management pty52.80K0.01%52.80K$40.10K
Envestnet asset management30.00K-30.00K$49.80K

Sold Out

HolderChange
Jpmorgan chase-69.00
Nova wealth management-500.00
Opal wealth advisors-500.00
Ifp advisors-1.00K
Coldstream capital management-1.24K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202638-51.28%15,601,171-27.18%212.84%16-51.52%5-68.75%
Dec 31, 202551-26.09%19,284,989-9.33%242.22%19-64.81%980.00%
Sep 30, 20256433.33%21,298,05889.46%3310.73%49172.22%4-42.86%
Jun 30, 202548-11,241,507-3.32%174.99%18-10.00%7-36.36%
Mar 31, 20251-97.78%6,000,000-45.80%91.29%--100.00%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.06M2.30%-
Vanguard Institutional Extnd Mkt Idx Tr874.81K0.98%-
Fidelity Extended Market Index432.04K0.48%10.65K
Extended Equity Market Fund E156.05K0.17%-
Blackrock Extended Mkt Fund CF156.05K0.17%-
Extended Equity Market Fund B156.05K0.17%-
BlackRock Extended Equity Market K64.70K0.16%-27.00
Fidelity Total Market Index143.77K0.16%-
Extended Equity Market Fund K132.87K0.15%-973.00
BlackRock Extended Equity Market Fund K132.87K0.15%-973.00

Recent Insider Transactions

DateNameRoleActivityValue
Apr 16, 2026Doyle John Brendan Chief Financial OfficerBuy$11.30K
Apr 16, 2026Ricciardi Lisa CEO & PresidentBuy$10.09K
Apr 16, 2026Caggiano Anthony Chief Medical OfficerBuy$11.10K
Jan 31, 2025Ricciardi Lisa CEO & PresidentBuy$30.00K
Mar 14, 2024Ricciardi Lisa CEO & PresidentBuy$9.97K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q11-

CGTX Ownership FAQ

Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 21.44%, followed by 2.25% insiders and 76.31% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 35.75%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 8.25%), Vanguard group (3.32M shares, 4.26%), and Davenport (2.89M shares, 3.98%). Together, they hold 16.48% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cognition Therapeutics.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.63% of its assets in 6M Cognition Therapeutics shares, valued at 4.56M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 2.30% of its total shares outstanding invested in 2.06M Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools